GL1X · GenesisL1 explorer

Research workbench

Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors

Analyse Application of crystallographic and modeling methods in the design of purine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ULA
Type
protein
Length
289 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Purine nucleoside phosphorylase
EC
2.4.2.1
UniProt
P00491
Ligands
SO4
Pockets
2 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APurine nucleoside phosphorylase (EC 2.4.2.1)protein28930% helix, 20% strandP00491

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13330.610.7846SO4
2640.450.8318empty

Compared structures

  • 1ULA · Application of crystallographic and modeling methods in the design of purine nucleoside… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00491 · AlphaFold monomer V2.0 prediction for purine nucleoside phosphorylase (P00491) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.